| 标题 |
APOB-48 shows potential as a biomarker to evaluate treatment response with apraglutide in short bowel syndrome, intestinal failure and colon-in-continuity |
| 网址 | |
| DOI |
10.1016/j.clnesp.2025.07.070
doi
|
| 其它 |
ABSTRACT ONLY Volume 69 P840 October 2025 A. Verbiest ∙ J. Tόth1 ∙ P. Bekker Jeppesen ∙ F. Joly ∙ T. Vanuytsel |
| 求助人 | |
| 下载 |